AUG 29, 2019 09:00 AM PDT

Enabling Next-Generation Targeted siRNA Therapies with ExpiCHO

Speakers
  • Postdoctoral Research Fellow, University of California San Diego
    Biography
      Dr. Ian Huggins is a postdoctoral researcher at University of California San Diego, where he builds advanced RNA interference triggers for the treatment of cancer and genetic disease. He specializes in the design, cloning and expression of engineered protein targeting domains and utilizes multiple bioconjugation chemistries and biochemical purification strategies to produce high quality targeted protein-siRNA triggers.

    Abstract:
    DATE:  August 29, 2019
    TIME:   9:00am PT / 12:00pm ET
     
    Monoclonal antibodies (mAbs) are a cornerstone of modern biomedical research and biotherapeutics. Therefore, reproducibly obtaining high yield and high purity mAbs while minimizing time and cost is critically important. In pursuit of this goal, we utilized the Gibco ExpiCHO Expression System to produce multiple mAbs. By optimizing several parameters, we obtained high yields from 30 mL shaker cultures at concentrations approaching 1 mg/mL in under 2 weeks. These results demonstrate the value of the ExpiCHO system as a game changing technology that brings high quantities of pure mAb within the reach of more scientists, enabling much more rapid and streamlined development of targeted therapies
     
    Learning Objectives:
    • Understand the need for high-yield and high-purity monoclonal antibodies for development of biotherapeutics.
    • Understand the value of the Gibco ExpiCHO Protein Expression System in production of monoclonal antibodies
     
     
    Webinars will be available for unlimited on-demand viewing after live event.

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    NOV 18, 2019 07:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    DEC 10, 2019 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 10, 2019 09:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    Loading Comments...
    Show Resources